Cost-effectiveness Analysis of4Therapeutic Regimens for Cervicitis of Chlamydia Trachomatis
Zhong Li
Abstract
Zhong Li
Abstract
OBJECTIVE:To evaluate the cost-effectiveness of 4 different therapeutic regimens for cervicitis of chlamydia trachomatis.METHODS:4therapeutic regimens including regimen A(azithromycin by oral administration),regimen B(azithromycin by intravenous injection),regimen C(minocycline by oral administration),regimen D(levofloxacin and deˉoxycycline by oral administration)were analyzed using cost-effectiveness analysis.RESULTS:The total costs of A,B,C,D4regimens were(645.20±109.56)yuan,(933.10±249.90)yuan,(413.14±38.04)yuan,and(489.00±83.60)yuan respectiveˉly;The effective rate were96.2%,98.6%,93.4%and94.1%respectively;The ratios of cost to effectiveness were6.71,9.46,4.42,and5.19respectively;As compared with regimen C,the incremental cost effectiveness ratios for regimen A,B and D were82.88,99.99,and108.37respectively.CONCLUSION:Regimen C is the preferable one.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To evaluate the cost-effectiveness of 4 different therapeutic regimens for cervicitis of chlamydia trachomatis.METHODS:4therapeutic regimens including regimen A(azithromycin by oral administration),regimen B(azithromycin by intravenous injection),regimen C(minocycline by oral administration),regimen D(levofloxacin and deˉoxycycline by oral administration)were analyzed using cost-effectiveness analysis.RESULTS:The total costs of A,B,C,D4regimens were(645.20±109.56)yuan,(933.10±249.90)yuan,(413.14±38.04)yuan,and(489.00±83.60)yuan respectiveˉly;The effective rate were96.2%,98.6%,93.4%and94.1%respectively;The ratios of cost to effectiveness were6.71,9.46,4.42,and5.19respectively;As compared with regimen C,the incremental cost effectiveness ratios for regimen A,B and D were82.88,99.99,and108.37respectively.CONCLUSION:Regimen C is the preferable one.
Key concepts: Regimen, Azithromycin, Medicine, Chlamydia trachomatis, Cervicitis, Internal medicine, Cost effectiveness, Levofloxacin